Document:

Exhibit
10.2

CRDENTIA MERGER VOTING AGREEMENT

This CRDENTIA
MERGER  VOTING AGREEMENT
(this “Agreement”) is made and
entered into as of September 20, 2006 (the “Effective Date”),
by and among Crdentia Corp., a Delaware corporation (“Crdentia”),
and MedCap Partners L.P. and MedCap
Master Fund L.P. (collectively,
“Shareholder”).

RECITALS

A.            This
Agreement is entered into in connection with that certain Agreement and Plan of
Reorganization (the “Merger Agreement”) dated as of
September 20, 2006, by and among iVOW, Crdentia Corp., a Delaware corporation (“Crdentia”), and iVOW Acquisition
Corp., a Delaware corporation and wholly-owned subsidiary of Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW
continuing as the surviving corporation of the merger and becoming a
wholly-owned subsidiary of Crdentia (the “Merger”).  Capitalized terms used in this Agreement
which are not otherwise defined herein will have the meanings given to such
terms in the Merger Agreement.

B.            As
of the Effective Date of this Agreement, Shareholder owns in the aggregate
(including shares held both beneficially and of record and other shares held
either beneficially or of record) the number of shares of Crdentia Common Stock
set forth below Shareholder’s name on the signature page of this Agreement (all
such shares together with any shares of voting stock of Crdentia that may
hereafter be acquired by Shareholder, being collectively referred to herein as
the “Subject Shares”).

C.            Shareholder
is entering into this Agreement as a material inducement to, and in
consideration of, iVOW’s willingness to enter into the Merger Agreement.

AGREEMENT

The parties to this Agreement, intending to be legally
bound, agree as follows:

1.             Transfer
of Subject Shares.

1.1          No
Disposition or Encumbrance of Subject Shares.  Shareholder agrees that, prior to the
Expiration Date, Shareholder will not, directly or indirectly, sell, transfer,
exchange, pledge or otherwise dispose of, or in any other way reduce
Shareholder’s risk of ownership or investment in, or make any offer or
agreement relating to any of the foregoing with respect to, any Subject Shares,
except pursuant to the Merger Agreement and except for distributions of shares
to Shareholder’s limited partners, or sales of shares with the proceeds
distributed to Shareholder’s limited partners, in the ordinary course of
Shareholder’s business consistent with the terms of the Shareholder’s Limited
Partnership Agreement made in order to satisfy Shareholder’s obligations to its
limited partners upon the redemption of fund interests in accordance with
Shareholder’s Limited Partnership Agreement. 
As used herein, the term “Expiration Date”
means the earliest to occur of (i) the Effective Time of the Merger, or (ii) 

 

such time as the Merger Agreement or this Agreement
may be terminated in accordance with their respective terms.

1.2          Transfer
of Voting Rights.  Shareholder
agrees that, prior to the Expiration Date, Shareholder will not deposit any of
the Subject Shares into a voting trust or grant a proxy or enter into an
agreement of any kind with respect to the voting of any of the Subject Shares,
except for the Proxy called for by Section 2.2 of this Agreement.

2.             Voting of Subject Shares.

2.1          Voting
Agreement.  Shareholder
agrees that, prior to the Expiration Date, at any meeting of the shareholders
of Crdentia, however called, and in any action taken by the written consent of
shareholders of Crdentia without a meeting to vote as set forth therein,
Shareholder will vote the Subject Shares:

(i)            in
favor of the Merger, the execution and delivery by Crdentia of the Merger
Agreement and the adoption and approval of the terms thereof and in favor of
each of the other actions and transactions contemplated by the Merger Agreement
and any action required in furtherance hereof and thereof;

(ii)           against
any action or agreement that would result in a breach of any representation,
warranty, covenant or obligation of Crdentia in the Merger Agreement or that
would preclude fulfillment of a condition precedent under the Merger Agreement
to Crdentia’s obligations to consummate the Merger; and

(iii)          against
any action which is intended, or could reasonably be expected to, impede,
interfere with, delay, postpone, discourage or adversely affect the Merger or
any of the other transactions contemplated by the Merger Agreement or this
Agreement.

Prior to the Expiration Date, Shareholder will not
enter into any agreement or understanding with any person or entity to vote or
give instructions in any manner inconsistent with this Section 2.1.

2.2          Proxy.  Contemporaneously with the
execution of this Agreement, Shareholder will deliver to Crdentia a proxy with
respect to the Subject Shares in the form attached hereto as Exhibit 1,
which proxy will be irrevocable to the fullest extent permitted by law (the “Proxy”) and will provide that
Crdentia may vote the Subject Shares in accordance with Section 2.1.

 2
 

 

 

3.             Representations,
Warranties and Covenants of Shareholder.  Shareholder hereby represents, warrants and
covenants as follows:

3.1          Authority,
Enforceability.  Shareholder
has the capacity and the full power and authority to enter into, execute,
deliver and perform Shareholder’s obligations under this Agreement and to make
the representations, warranties and covenants contained herein, and that all
corporate or similar action required for the authorization, execution, delivery
and the performance of all obligations of Shareholder under this Agreement and
the agreements contemplated hereby have been obtained.  This Agreement has been duly executed and
delivered by Shareholder and constitutes a legal, valid and binding obligation
of Shareholder, enforceable against Shareholder in accordance with its terms.

3.2          Shares
Owned.  As of the
Effective Date of this Agreement, Shareholder owns in the aggregate (including
shares held both beneficially and of record and other shares held either
beneficially or of record) the number of shares of Crdentia Common Stock and
other securities of Crdentia set forth below Shareholder’s name on the
signature page of this Agreement, and does not directly or indirectly own,
either beneficially or of record, any shares of capital stock of Crdentia, or
rights to acquire any shares of capital stock of Crdentia, or other securities
of Crdentia, other than the securities set forth below Shareholder’s name on
the signature page hereof.

3.3          Further
Assurances. 
Shareholder agrees to execute and deliver any additional documents
reasonably necessary or desirable, in the opinion of Crdentia, to carry out the
purposes and intent of this Agreement and the Proxy.

4.             Miscellaneous.

4.1          Severability.  If any provision of this
Agreement, or the application thereof, will for any reason and to any extent be
invalid or unenforceable, the remainder of this Agreement and application of
such provision to other persons or circumstances will be interpreted so as to
reasonably effect the intent of the parties hereto.

4.2          Amendment and Waiver.  This Agreement or any provision hereof may be
amended, modified, superseded, canceled, renewed, waived or extended only by an
agreement in writing executed by Crdentia and Shareholder.  The waiver by a party of any breach hereof or
default in the performance hereof will not be deemed to constitute a waiver of
any other default or any succeeding breach or default.

4.3          Assignment.  This Agreement and all rights and obligations
hereunder are personal to Shareholder and may not be transferred or assigned by
Shareholder at any time.  Crdentia may
assign its rights, together with its obligations hereunder, to any parent,
subsidiary, affiliate or successor of Crdentia, as the case may be.  This Agreement will be binding upon, and
inure to the benefit of, the persons or entities who are permitted, by the
terms of this Agreement, to be successors, assigns and personal representatives
of the respective parties hereto.

 3
 

 

 

4.4          Governing
Law.  The validity,
interpretation and enforcement of this Agreement will be governed by and
construed in accordance with the internal laws of the State of Delaware,
excluding that body of laws pertaining to conflict of laws.

4.5          Costs of Enforcement.  If any party to this Agreement seeks to
enforce its rights under this Agreement by legal proceedings or otherwise, the
non-prevailing party will pay all costs and expenses incurred by the prevailing
party, including, without limitation, all reasonable attorneys’ and experts’
fees.

4.6          Counterparts.  This Agreement may be executed in
counterparts, each of which will be deemed an original but all of which, taken
together, constitute one and the same agreement.

4.7          Entire
Agreement.  This
Agreement and the documents referred to herein constitute the entire agreement
and understanding of the parties with respect to the subject matter of this
Agreement, and supersede all prior understandings and agreements, whether oral
or written, between or among the parties hereto with respect to the specific
subject matter hereof.

4.8          Specific
Performance; Injunctive Relief.  The parties hereto acknowledge that Crdentia
will be irreparably harmed and that there will be no adequate remedy at law for
a violation of any of the covenants or agreements of Shareholder set forth
herein.  Therefore, it is agreed that, in
addition to any other remedies that may be available to Crdentia upon any such violation,
Crdentia shall have the right to enforce such covenants and agreements by
specific performance, injunctive relief or by any other means available to
Crdentia at law or in equity.

4.9          Notices.  All notices and other communications required
or permitted under this Agreement shall be in writing and shall be either hand
delivered in person, sent by facsimile (with confirmation of receipt), sent by
certified or registered first class mail, postage pre-paid, or sent by
nationally recognized express courier service. 
Such notices and other communications will be effective upon receipt if
hand delivered or sent by facsimile (provided the sender receives confirmation
of receipt), three (3) business days after mailing if sent by mail, and one (1)
business day after dispatch if sent by express courier, to the following
addresses:

If to Crdentia:

Crdentia Corp.

15001 LBJ Freeway, Suite 850

Dallas, TX  75244

Attention:  Chief Executive Officer

Facsimile No.: (972) 392-2722

with a copy to:

Morrison & Foerster LLP

12531 High Bluff Drive, Suite 100

 4
 

 

San Diego, CA  92130

Attention: Stephen Rowles 

Facsimile No.: (858) 720-5125

If to Shareholder:

To the address for
Shareholder set forth on the signature page hereof;

or to such other address
as a party may have furnished to the other parties in writing pursuant to this Section
4.9.

[Remainder of Page Intentionally Left Blank]

 

 5

 

IN WITNESS WHEREOF, the undersigned parties have executed this
Agreement as of the date first above written. 

	
  Crdentia Corp.

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Name:

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  SHAREHOLDER

  	
   

  
	
   

  	
   

  
	
  MEDCAP PARTNERS L.P.

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
  Its:

  	
   

  	
   

  	
   

  

 

Crdentia Common Stock:               shares

Other Rights to Acquire Crdentia Stock:   Warrants to purchase       
shares of Common Stock

Address:

	
  MEDCAP MASTER FUND L.P.

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
  Its:

  	
   

  	
   

  	
   

  

 

Crdentia Common Stock:               shares

Other Rights to Acquire Crdentia Stock:   Warrants to purchase                
shares of Common Stock

Address:

[Signature
Page to Crdentia Voting Agreement]

 

EXHIBIT 1 TO IVOW MERGER VOTING AGREEMENT

IRREVOCABLE PROXY

The undersigned
shareholders of Crdentia Corp., a Delaware corporation (“Crdentia”),
hereby irrevocably (to the fullest extent permitted by law) appoint and
constitute James D. Durham of Crdentia the attorney and proxy of the
undersigned, with full power of substitution and resubstitution, to the extent
described below and, with respect to such matters, to the fullest extent of the
undersigned’s rights with respect to (i) the shares of capital stock of
Crdentia owned by the undersigned as of the date of this proxy, which shares
are specified on the final page of this proxy, to the extent still owned by the
undersigned on the requisite record date, and (ii) any and all other
shares of capital stock of Crdentia which the undersigned may acquire after the
date hereof (all such shares described in clause (i) or (ii), being
collectively referred to herein as the “Shares”).  Upon the execution hereof, all prior proxies
given by the undersigned with respect to any of the Shares are hereby revoked,
and no subsequent proxies will be given with respect to any of the Shares.

This proxy is granted in
consideration of Crdentia entering into the Agreement and Plan of
Reorganization (the “Merger Agreement”) dated as of
September 20, 2006, by and among iVOW, Inc., a Delaware corporation (“iVOW”), Crdentia, and iVOW
Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of
Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW
continuing as the surviving corporation of the merger and becoming a
wholly-owned subsidiary of Crdentia (the “Merger”).  This proxy is irrevocable, and is coupled
with an interest and is granted in connection with that certain Crdentia Merger
Voting Agreement dated as of the date hereof, by and between Crdentia and the
undersigned (the “Voting
Agreement”).  Capitalized
terms used in this proxy which are not defined herein will have the meanings
given to such terms in the Voting Agreement.

The attorney and proxy
named above will be empowered, and may exercise this proxy, to vote the Shares
at any time until the Expiration Date at any meeting of the shareholders of
Crdentia, however called, or in any action by written consent of shareholders
of Crdentia:

(i)            in favor of the Merger, the
execution and delivery by Crdentia of the Merger Agreement and the adoption and
approval of the terms thereof and in favor of each of the other actions and
transactions contemplated by the Merger Agreement and any action required in
furtherance hereof and thereof;

(ii)           against any action or agreement that
would result in a breach of any representation, warranty, covenant or
obligation of Crdentia in the Merger Agreement or that would preclude
fulfillment of a condition precedent under the Merger Agreement to Crdentia’s
respective to consummate the Merger; and

(iii)          against any other action which is
intended, or could reasonably be expected to, impede, interfere with, delay,
postpone, discourage or adversely affect the Merger or any of the other
transactions contemplated by the Merger Agreement or this Agreement.

The attorneys and proxies
named above may not exercise this Proxy on any other matter except as provided
above.  The undersigned shareholder may
vote the Shares on all other matters.

This proxy will be
binding upon the heirs, successors and assigns of the undersigned (including
any transferee of any of the Shares).

[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK]

 2

 

This proxy will terminate upon the Expiration Date.

Dated: 
September 20, 2006

CRDENTIA SHAREHOLDER

	
  MEDCAP PARTNERS L.P.

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
  Its:

  	
   

  	
   

  	
   

  

 

Crdentia Common Stock:               shares

Other Rights to Acquire Crdentia Stock:   Warrants to purchase      
shares of Common Stock

Address:

	
  MEDCAP MASTER FUND L.P.

  
	
   

  	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
  Its:

  	
   

  	
   

  	
   

  

 

Crdentia Common Stock:               shares

Other Rights to Acquire Crdentia Stock:   Warrants to purchase      
shares of Common Stock

Address:

[Signature
Page to Irrevocable Proxy]Exhibit
10.3

IVOW MERGER VOTING AGREEMENT

This IVOW MERGER
VOTING AGREEMENT (this “Agreement”) is made and entered
into as of September 20, 2006 (the “Effective Date”),
by and among iVOW, Inc., a Delaware corporation (“iVOW”),
and MedCap Partners L.P. and MedCap
Master Fund L.P. (collectively,
“Shareholder”).

RECITALS

A.            This
Agreement is entered into in connection with that certain Agreement and Plan of
Reorganization (the “Merger Agreement”) dated as of
September 20, 2006, by and among iVOW, Crdentia Corp., a Delaware corporation (“Crdentia”), and iVOW Acquisition
Corp. a Delaware corporation and wholly-owned subsidiary of Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW
continuing as the surviving corporation of the merger and becoming a
wholly-owned subsidiary of Crdentia (the “Merger”).  Capitalized terms used in this Agreement
which are not otherwise defined herein will have the meanings given to such
terms in the Merger Agreement.

B.            As
of the Effective Date of this Agreement, Shareholder owns in the aggregate
(including shares held both beneficially and of record and other shares held
either beneficially or of record) the number of shares of iVOW Common Stock set
forth below Shareholder’s name on the signature page of this Agreement (all
such shares together with any shares of voting stock of iVOW that may hereafter
be acquired by Shareholder, being collectively referred to herein as the “Subject Shares”).

C.            Shareholder
is entering into this Agreement as a material inducement to, and in
consideration of, Crdentia’s willingness to enter into the Merger Agreement.

AGREEMENT

The parties to this Agreement, intending to be legally
bound, agree as follows:

1.             Transfer
of Subject Shares.

1.1          No
Disposition or Encumbrance of Subject Shares.  Shareholder agrees that, prior to the
Expiration Date, Shareholder will not, directly or indirectly, sell, transfer,
exchange, pledge or otherwise dispose of, or in any other way reduce
Shareholder’s risk of ownership or investment in, or make any offer or
agreement relating to any of the foregoing with respect to, any Subject Shares,
except pursuant to the Merger Agreement and except for distributions of shares
to Shareholder’s limited partners, or sales of shares with the proceeds
distributed to Shareholder’s limited partners, in the ordinary course of
Shareholder’s business consistent with the terms of the Shareholder’s Limited
Partnership Agreement made in order to satisfy Shareholder’s obligations to its
limited partners upon the redemption of fund interests in accordance with
Shareholder’s Limited Partnership Agreement. 
As used herein, the term “Expiration Date”
means the earliest to occur of (i) the Effective Time of the Merger, or (ii) 

 

such time as the Merger Agreement or this Agreement
may be terminated in accordance with their respective terms.

1.2          Transfer
of Voting Rights.  Shareholder
agrees that, prior to the Expiration Date, Shareholder will not deposit any of
the Subject Shares into a voting trust or grant a proxy or enter into an
agreement of any kind with respect to the voting of any of the Subject Shares,
except for the Proxy called for by Section 2.2 of this Agreement.

2.             Voting of Subject Shares.

2.1          Voting
Agreement.  Shareholder
agrees that, prior to the Expiration Date, at any meeting of the shareholders
of iVOW, however called, and in any action taken by the written consent of
shareholders of iVOW without a meeting to vote as set forth therein,
Shareholder will vote the Subject Shares:

(i)            in
favor of the Merger, the execution and delivery by iVOW of the Merger Agreement
and the adoption and approval of the terms thereof and in favor of each of the
other actions and transactions contemplated by the Merger Agreement and any
action required in furtherance hereof and thereof;

(ii)           against
any action or agreement that would result in a breach of any representation,
warranty, covenant or obligation of iVOW in the Merger Agreement or that would
preclude fulfillment of a condition precedent under the Merger Agreement to
iVOW’s obligations to consummate the Merger; and

(iii)          against
the following actions (other than the Merger and the transactions contemplated
by the Merger Agreement):  (A) the sale
or exchange of iVOW’s capital stock, other than (x) upon exercise or conversion
of iVOW’s outstanding options, warrants or notes, or (y) to any employee,
consultant or director of iVOW for purposes of retaining their services, (B)
the merger of iVOW with, or the direct or indirect disposition of a significant
amount of the assets or the business of iVOW to, any third party, or (C) the
licensing of iVOW IP Rights to any third party other than licensing
transactions which are in the ordinary course of iVOW’s business and not
material to iVOW or its business (each of the actions described in clauses (A),
(B) and (C) being referred to herein as an “Alternative Transaction”);
(D) any reorganization, recapitalization, dissolution or liquidation of iVOW or
any subsidiary of iVOW; (E) any material change in the capitalization of iVOW or
iVOW’s corporate structure not contemplated by the Merger Agreement; or (F) any
other action which is intended, or could reasonably be expected to, impede,
interfere with, delay, postpone, discourage or adversely affect the Merger or
any of the other transactions contemplated by the Merger Agreement or this
Agreement.

Prior to the Expiration Date, Shareholder will not
enter into any agreement or understanding with any person or entity to vote or
give instructions in any manner inconsistent with this Section 2.1.

 2
 

 

 

2.2          Proxy.  Contemporaneously with the
execution of this Agreement, Shareholder will deliver to iVOW a proxy with
respect to the Subject Shares in the form attached hereto as Exhibit 1,
which proxy will be irrevocable to the fullest extent permitted by law (the “Proxy”) and will provide that iVOW
may vote the Subject Shares in accordance with Section 2.1.

 3
 

 

 

3.             No
Solicitation.  From
the date hereof until the Expiration Date, Shareholder will not, and will not
authorize or permit any agent or representative of Shareholder to, directly or
indirectly:  (i) solicit, initiate or
induce the making, submission or announcement of any Company Acquisition
Proposal (as that term is defined in the Merger Agreement), (ii) participate in
any discussions or negotiations regarding, or furnish to any person any
non-public information with respect to, or take any other action to facilitate
any inquiries or the making of any proposal that constitutes or may reasonably
be expected to lead to, any Company Acquisition Proposal, (iii) engage in
discussions with any person with respect to any Company Acquisition Proposal,
except as to disclose the existence of these provisions, (iv) endorse or
recommend any Company Acquisition Proposal, or (v) enter into any letter of intent
or similar document or any contract, agreement or commitment contemplating or
otherwise relating to any Company Acquisition Proposal.  If Shareholder becomes aware of any such
offer, or any discussions, negotiations, inquiries, proposals or contacts with
respect to any Company Acquisition Proposal, Shareholder agrees to advise iVOW
in writing of any Company Acquisition Proposal or of any request for nonpublic
information or other inquiry which the party reasonably believes could lead to
a Company Acquisition Proposal, the material terms and conditions of such
Company Acquisition Proposal (to the extent known), and the identity of the
person or group making any such request, inquiry or Company Acquisition
Proposal.

4.             Representations,
Warranties and Covenants of Shareholder.  Shareholder hereby represents, warrants and
covenants as follows:

4.1          Authority,
Enforceability.  Shareholder
has the capacity and the full power and authority to enter into, execute,
deliver and perform Shareholder’s obligations under this Agreement and to make
the representations, warranties and covenants contained herein, and that all
corporate or similar action required for the authorization, execution, delivery
and the performance of all obligations of Shareholder under this Agreement and
the agreements contemplated hereby have been obtained.  This Agreement has been duly executed and
delivered by Shareholder and constitutes a legal, valid and binding obligation
of Shareholder, enforceable against Shareholder in accordance with its terms.

4.2          Shares
Owned.  As of the
Effective Date of this Agreement, Shareholder owns in the aggregate (including
shares held both beneficially and of record and other shares held either
beneficially or of record) the number of shares of iVOW Common Stock and other
securities of iVOW set forth below Shareholder’s name on the signature page of
this Agreement, and does not directly or indirectly own, either beneficially or
of record, any shares of capital stock of iVOW, or rights to acquire any shares
of capital stock of iVOW, or other securities of iVOW, other than the
securities set forth below Shareholder’s name on the signature page hereof.

4.3          Further
Assurances. 
Shareholder agrees to execute and deliver any additional documents
reasonably necessary or desirable, in the opinion of iVOW, to carry out the
purposes and intent of this Agreement and the Proxy.

 4
 

 

 

5.             Miscellaneous.

5.1          Severability.  If any provision of this
Agreement, or the application thereof, will for any reason and to any extent be
invalid or unenforceable, the remainder of this Agreement and application of
such provision to other persons or circumstances will be interpreted so as to
reasonably effect the intent of the parties hereto.

5.2          Amendment and Waiver.  This Agreement or any provision hereof may be
amended, modified, superseded, canceled, renewed, waived or extended only by an
agreement in writing executed by iVOW and Shareholder.  The waiver by a party of any breach hereof or
default in the performance hereof will not be deemed to constitute a waiver of
any other default or any succeeding breach or default.

5.3          Assignment.  This Agreement and all rights and obligations
hereunder are personal to Shareholder and may not be transferred or assigned by
Shareholder at any time.  iVOW may assign
its rights, together with its obligations hereunder, to any parent, subsidiary,
affiliate or successor of iVOW, as the case may be.  This Agreement will be binding upon, and
inure to the benefit of, the persons or entities who are permitted, by the terms
of this Agreement, to be successors, assigns and personal representatives of
the respective parties hereto.

5.4          Governing
Law.  The validity,
interpretation and enforcement of this Agreement will be governed by and
construed in accordance with the internal laws of the State of Delaware,
excluding that body of laws pertaining to conflict of laws.

5.5          Costs of Enforcement.  If any party to this Agreement seeks to
enforce its rights under this Agreement by legal proceedings or otherwise, the
non-prevailing party will pay all costs and expenses incurred by the prevailing
party, including, without limitation, all reasonable attorneys’ and experts’
fees.

5.6          Counterparts.  This Agreement may be executed in
counterparts, each of which will be deemed an original but all of which, taken
together, constitute one and the same agreement.

5.7          Entire
Agreement.  This
Agreement and the documents referred to herein constitute the entire agreement
and understanding of the parties with respect to the subject matter of this
Agreement, and supersede all prior understandings and agreements, whether oral
or written, between or among the parties hereto with respect to the specific
subject matter hereof.

5.8          Specific
Performance; Injunctive Relief.  The parties hereto acknowledge that iVOW will
be irreparably harmed and that there will be no adequate remedy at law for a
violation of any of the covenants or agreements of Shareholder set forth
herein.  Therefore, it is agreed that, in
addition to any other remedies that may be available to iVOW upon any such
violation, iVOW shall have the right to enforce such covenants and agreements
by specific performance, injunctive relief or by any other means available to
iVOW at law or in equity.

 5
 

 

 

5.9          Notices.  All notices and other communications required
or permitted under this Agreement shall be in writing and shall be either hand
delivered in person, sent by facsimile (with confirmation of receipt), sent by
certified or registered first class mail, postage pre-paid, or sent by
nationally recognized express courier service. 
Such notices and other communications will be effective upon receipt if
hand delivered or sent by facsimile (provided the sender receives confirmation
of receipt), three (3) business days after mailing if sent by mail, and one (1)
business day after dispatch if sent by express courier, to the following
addresses:

If to iVOW:

iVOW, Inc.

11455 El Camino Real, Suite 140

San Diego, CA  92130

Attention:  Chief Executive Officer

Facsimile No.: (858) 847-4811

with a copy to:

Heller Ehrman LLP

4350 La Jolla Village Drive, 7th Floor

San Diego, CA  92122

Attention: Michael S. Kagnoff

Facsimile No.: (858) 450-8499

If to Shareholder:

To the address for
Shareholder set forth on the signature page hereof;

or to such other address
as a party may have furnished to the other parties in writing pursuant to this Section
5.9.

[Remainder of Page Intentionally Left Blank]

 

 6

 

IN
WITNESS WHEREOF, the undersigned parties have executed this
Agreement as of the date first above written.

	
  iVOW, Inc.

  	
   

  
	
   

  	
   

  
	
  By:

  	
   

  	
   

  
	
   

  	
   

  
	
  Name:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  SHAREHOLDER

  	
   

  
	
   

  	
   

  
	
  MEDCAP PARTNERS L.P.

  	
   

  
	
   

  	
   

  
	
  By:

  	
   

  	
   

  
	
  Its:

  	
   

  	
   

  
					

 

VOW Common Stock:                shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase      shares
of Common Stock

Address:

	
  MEDCAP MASTER FUND L.P.

  
	
   

  
	
  By:

  	
   

  	
   

  	 

	
  Its:

  	
   

  	
   

  	 

 

iVOW Common Stock:                shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase      
shares of Common Stock

Address:

[Signature Page to iVOW Merger Voting Agreement]

 

EXHIBIT 1 TO IVOW MERGER VOTING
AGREEMENT

IRREVOCABLE PROXY

The undersigned shareholders of iVOW, Inc., a Delaware
corporation (“iVOW”), hereby irrevocably
(to the fullest extent permitted by law) appoint and constitute John Lyon or
Richard Gomberg of iVOW, and each of them, the attorneys and proxies of the
undersigned, with full power of substitution and resubstitution, to the extent
described below and, with respect to such matters, to the fullest extent of the
undersigned’s rights with respect to (i) the shares of capital stock of
iVOW owned by the undersigned as of the date of this proxy, which shares are
specified on the final page of this proxy, to the extent still owned by the
undersigned on the requisite record date, and (ii) any and all other
shares of capital stock of iVOW which the undersigned may acquire after the
date hereof (all such shares described in clause (i) or (ii), being
collectively referred to herein as the “Shares”).  Upon the execution hereof, all prior proxies
given by the undersigned with respect to any of the Shares are hereby revoked,
and no subsequent proxies will be given with respect to any of the Shares.

This proxy is granted in consideration of iVOW
entering into the Agreement and Plan of Reorganization (the “Merger Agreement”)
dated as of September 20, 2006, by and among iVOW, Crdentia Corp., a Delaware
corporation (“Crdentia”), and iVOW
Acquisition Corp. a Delaware corporation and wholly-owned subsidiary of
Crdentia (“Merger Sub”)
pursuant to which Merger Sub will merge with and into iVOW, with iVOW
continuing as the surviving corporation of the merger and becoming a
wholly-owned subsidiary of Crdentia (the “Merger”).  This proxy is irrevocable, and is coupled
with an interest and is granted in connection with that certain iVOW Merger
Voting Agreement dated as of the date hereof, by and between iVOW and the
undersigned (the “Voting
Agreement”).  Capitalized
terms used in this proxy which are not defined herein will have the meanings
given to such terms in the Voting Agreement.

The attorneys and proxies named above will be
empowered, and may exercise this proxy, to vote the Shares at any time until
the Expiration Date at any meeting of the shareholders of iVOW, however called,
or in any action by written consent of shareholders of iVOW:

(i)            in
favor of the Merger, the execution and delivery by iVOW of the Merger Agreement
and the adoption and approval of the terms thereof and in favor of each of the
other actions and transactions contemplated by the Merger Agreement and any
action required in furtherance hereof and thereof;

(ii)           against
any action or agreement that would result in a breach of any representation,
warranty, covenant or obligation of iVOW in the Merger Agreement or that would
preclude fulfillment of a condition precedent under the Merger Agreement to
iVOW’s respective to consummate the Merger; and

(iii)          against
the following actions (other than the Merger and the transactions contemplated
by the Merger Agreement): (A) the sale or exchange of iVOW’s 

 

capital stock, other than (x) upon exercise or
conversion of iVOW’s outstanding options, warrants or notes, or (y) to any
employee, consultant or director of iVOW for purposes of retaining their
services, (B) the merger of iVOW with, or the direct or indirect disposition of
a significant amount of the assets or the business of iVOW to, any third party,
or (C) the licensing of iVOW IP Rights to any third party other than licensing
transactions which are in the ordinary course of Vanguard’s business and not
material to iVOW or its business (each of the actions described in clauses (A),
(B) and (C) being referred to herein as an “Alternative Transaction”); (D) any
reorganization, recapitalization, dissolution or liquidation of iVOW or any
subsidiary of iVOW; (E) any material change in the capitalization of iVOW or
iVOW’s corporate structure not contemplated by the Merger Agreement; or (F) any
other action which is intended, or could reasonably be expected to, impede,
interfere with, delay, postpone, discourage or adversely affect the Merger or
any of the other transactions contemplated by the Merger Agreement or this
Agreement.

The attorneys and proxies named above may not exercise
this Proxy on any other matter except as provided above.  The undersigned shareholder may vote the Shares
on all other matters.

This proxy will be binding upon the heirs, successors
and assigns of the undersigned (including any transferee of any of the Shares).

[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK]

 

 2

 

This proxy will terminate
upon the Expiration Date.

Dated: 
September 20, 2006

iVOW
SHAREHOLDER

	
  MEDCAP PARTNERS L.P.

  	
   

  
	
   

  	
   

  
	
  By:

  	
   

  	
   

  
	
  Its:

  	
   

  	
   

  

 

VOW Common Stock:                shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase      shares
of Common Stock

Address:

	
  MEDCAP MASTER FUND L.P.

  
	
   

  
	
  By:

  	
   

  	
   

  	 

	
  Its:

  	
   

  	
   

  	 

 

iVOW Common Stock:                shares

Other Rights to Acquire
iVOW Stock:   Warrants to purchase      
shares of Common Stock

Address:

[Signature
Page to Irrevocable Proxy]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]